Clinical Trial Update: Safety, Tolerability, and PK of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli [Phase 1]

View source ↗

Summary

Phase 1 trial update on safety, tolerability, and pharmacokinetics of LBP-EC01 in patients with urinary tract colonization by E. coli; completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• LBP-EC01

Snippet

Sponsor: Locus Biosciences | Conditions: Urinary Tract Infections | Phase 1 | Status: COMPLETED | Results posted: 2022-03-16